{
  "DOI": "10.1007/s10689-016-9875-7",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-016-9875-7",
  "alternative-id": [
    "9875"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Nielsen",
      "given": "Henriette Roed",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Nilbert",
      "given": "Mef",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Petersen",
      "given": "Janne",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ladelund",
      "given": "Steen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Thomassen",
      "given": "Mads",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pedersen",
      "given": "Inge Søkilde",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hansen",
      "given": "Thomas V. O.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Skytte",
      "given": "Anne-Bine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Borg",
      "given": "Åke",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Therkildsen",
      "given": "Christina",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2016,
        2,
        1
      ]
    ],
    "date-time": "2016-02-01T09:00:55Z",
    "timestamp": 1454317255000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:46:17Z",
    "timestamp": 1559252777000
  },
  "funder": [
    {
      "name": "Aase and Ejnar Danielsen’s Fund"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        6
      ]
    ],
    "date-time": "2023-09-06T19:46:27Z",
    "timestamp": 1694029587145
  },
  "is-referenced-by-count": 9,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2016,
        2,
        1
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2016,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2016,
            2,
            1
          ]
        ],
        "date-time": "2016-02-01T00:00:00Z",
        "timestamp": 1454284800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-016-9875-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-016-9875-7/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-016-9875-7",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "507-512",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2016,
        2,
        1
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2016,
        2,
        1
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2016,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S0140-6736(94)91578-4",
      "author": "D Ford",
      "doi-asserted-by": "crossref",
      "first-page": "692",
      "journal-title": "Lancet",
      "key": "9875_CR1",
      "unstructured": "Ford D, Easton DF, Bishop DT et al (1994) Risks of cancer in BRCA1-mutation carriers. Breast cancer linkage consortium. Lancet 343:692–695",
      "volume": "343",
      "year": "1994"
    },
    {
      "DOI": "10.1086/301749",
      "author": "D Ford",
      "doi-asserted-by": "crossref",
      "first-page": "676",
      "journal-title": "Am J Hum Genet",
      "key": "9875_CR2",
      "unstructured": "Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62:676–689",
      "volume": "62",
      "year": "1998"
    },
    {
      "DOI": "10.1086/513891",
      "author": "DF Easton",
      "doi-asserted-by": "crossref",
      "first-page": "120",
      "journal-title": "Am J Hum Genet",
      "key": "9875_CR3",
      "unstructured": "Easton DF, Steele L, Fields P et al (1997) Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 61:120–128",
      "volume": "61",
      "year": "1997"
    },
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1117",
      "journal-title": "Am J Hum Genet",
      "key": "9875_CR4",
      "unstructured": "Antoniou A, Pharoah PDP, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130",
      "volume": "72",
      "year": "2003"
    },
    {
      "DOI": "10.1126/science.1088759",
      "author": "M-C King",
      "doi-asserted-by": "crossref",
      "first-page": "643",
      "journal-title": "Science",
      "key": "9875_CR5",
      "unstructured": "King M-C, Marks JH, Handell JB (2003) Breast and ovarian cancer risks due to inherited mutationsin BRCA1 and BRCA2. Science 302:643–646",
      "volume": "302",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2006.09.1066",
      "author": "S Chen",
      "doi-asserted-by": "crossref",
      "first-page": "1329",
      "journal-title": "J Clin Oncol",
      "key": "9875_CR6",
      "unstructured": "Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329–1333",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1038/ng0197-103",
      "author": "SA Gayther",
      "doi-asserted-by": "crossref",
      "first-page": "103",
      "journal-title": "Nat Genet",
      "key": "9875_CR7",
      "unstructured": "Gayther SA, Mangion J, Russell P et al (1997) Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 15:103–105",
      "volume": "15",
      "year": "1997"
    },
    {
      "DOI": "10.1086/318181",
      "author": "D Thompson",
      "doi-asserted-by": "crossref",
      "first-page": "410",
      "journal-title": "Am J Hum Genet",
      "key": "9875_CR8",
      "unstructured": "Thompson D, Easton D, Breast Cancer Linkage Consortium (2001) Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 68:410–419",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-11-0775",
      "author": "N Mavaddat",
      "doi-asserted-by": "publisher",
      "first-page": "134",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "9875_CR9",
      "unstructured": "Mavaddat N, Barrowdale D, Andrulis IL et al (2012) Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomark Prev 21:134–147. doi: 10.1158/1055-9965.EPI-11-0775",
      "volume": "21",
      "year": "2012"
    },
    {
      "DOI": "10.1001/jama.2014.5985",
      "author": "TR Rebbeck",
      "doi-asserted-by": "publisher",
      "first-page": "1347",
      "journal-title": "JAMA",
      "key": "9875_CR10",
      "unstructured": "Rebbeck TR, Mitra N, Wan F et al (2015) Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA 313:1347–1361. doi: 10.1001/jama.2014.5985",
      "volume": "313",
      "year": "2015"
    },
    {
      "DOI": "10.1038/sj.ejhg.5200529",
      "author": "L Sarantaus",
      "doi-asserted-by": "crossref",
      "first-page": "757",
      "journal-title": "Eur J Hum Genet",
      "key": "9875_CR11",
      "unstructured": "Sarantaus L, Huusko P, Eerola H et al (2000) Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland. Eur J Hum Genet 8:757–763",
      "volume": "8",
      "year": "2000"
    },
    {
      "author": "L Sarantaus",
      "first-page": "831",
      "journal-title": "Int J Oncol",
      "key": "9875_CR12",
      "unstructured": "Sarantaus L, Auranen A, Nevanlinna H (2001) BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families. Int J Oncol 18:831–835",
      "volume": "18",
      "year": "2001"
    },
    {
      "author": "G Johannesdottir",
      "first-page": "3663",
      "journal-title": "Cancer Res",
      "key": "9875_CR13",
      "unstructured": "Johannesdottir G, Gudmundsson J, Bergthorsson JT et al (1996) High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res 56:3663–3665",
      "volume": "56",
      "year": "1996"
    },
    {
      "DOI": "10.1038/ng0596-117",
      "author": "S Thorlacius",
      "doi-asserted-by": "crossref",
      "first-page": "117",
      "journal-title": "Nat Genet",
      "key": "9875_CR14",
      "unstructured": "Thorlacius S, Olafsdottir G, Tryggvadottir L et al (1996) A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13:117–119",
      "volume": "13",
      "year": "1996"
    },
    {
      "DOI": "10.1093/jnci/djm005",
      "author": "L Tryggvadóttir",
      "doi-asserted-by": "crossref",
      "first-page": "929",
      "journal-title": "J Natl Cancer Inst",
      "key": "9875_CR15",
      "unstructured": "Tryggvadóttir L, Vidarsdóttir L, Thorgeirsson T et al (2007) Prostate cancer progression and survival in BRCA2 mutation carriers. J Natl Cancer Inst 99:929–935",
      "volume": "99",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.ejhg.5200704",
      "author": "A Bergman",
      "doi-asserted-by": "crossref",
      "first-page": "787",
      "journal-title": "Eur J Hum Genet",
      "key": "9875_CR16",
      "unstructured": "Bergman A, Einbeigi Z, Olofsson U et al (2001) The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation. Eur J Hum Genet 9:787–793",
      "volume": "9",
      "year": "2001"
    },
    {
      "DOI": "10.1007/s10689-004-5812-2",
      "author": "A Bergman",
      "doi-asserted-by": "crossref",
      "first-page": "89",
      "journal-title": "Fam Cancer",
      "key": "9875_CR17",
      "unstructured": "Bergman A, Flodin A, Engwall Y et al (2005) A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques. Fam Cancer 4:89–96",
      "volume": "4",
      "year": "2005"
    },
    {
      "DOI": "10.1111/j.1399-0004.2012.01855.x",
      "author": "P Møller",
      "doi-asserted-by": "publisher",
      "first-page": "88",
      "journal-title": "Clin Genet",
      "key": "9875_CR18",
      "unstructured": "Møller P, Mæhle L, Vabø A et al (2013) Age-specific incidence rates for breast cancer in carriers of BRCA1 mutations from Norway. Clin Genet 83:88–91. doi: 10.1111/j.1399-0004.2012.01855.x",
      "volume": "83",
      "year": "2013"
    },
    {
      "DOI": "10.1200/JCO.20.6.1480",
      "author": "TS Frank",
      "doi-asserted-by": "crossref",
      "first-page": "1480",
      "journal-title": "J Clin Oncol",
      "key": "9875_CR19",
      "unstructured": "Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480–1490",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1023/B:FAME.0000026816.32400.45",
      "author": "J Lubinski",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "Fam Cancer",
      "key": "9875_CR20",
      "unstructured": "Lubinski J, Phelan CM, Ghadirian P et al (2004) Cancer variation associated with the position of the mutation in the BRCA2 gene. Fam Cancer 3:1–10",
      "volume": "3",
      "year": "2004"
    },
    {
      "DOI": "10.1002/cncr.26191",
      "author": "ZK Stadler",
      "doi-asserted-by": "publisher",
      "first-page": "493",
      "journal-title": "Cancer",
      "key": "9875_CR21",
      "unstructured": "Stadler ZK, Salo-Mullen E, Patil SM et al (2012) Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. Cancer 118:493–499. doi: 10.1002/cncr.26191",
      "volume": "118",
      "year": "2012"
    },
    {
      "DOI": "10.1080/02841860802004974",
      "author": "M Thomassen",
      "doi-asserted-by": "publisher",
      "first-page": "772",
      "journal-title": "Acta Oncol",
      "key": "9875_CR22",
      "unstructured": "Thomassen M, Hansen TVO, Borg Å et al (2008) BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer. Acta Oncol 47:772–777. doi: 10.1080/02841860802004974",
      "volume": "47",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s10549-010-1272-6",
      "author": "M Thomassen",
      "doi-asserted-by": "publisher",
      "first-page": "179",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9875_CR23",
      "unstructured": "Thomassen M, Pedersen IS, Vogel I et al (2010) A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicing. Breast Cancer Res Treat 128:179–185. doi: 10.1007/s10549-010-1272-6",
      "volume": "128",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10549-008-0088-0",
      "author": "TV Hansen",
      "doi-asserted-by": "publisher",
      "first-page": "315",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9875_CR24",
      "unstructured": "Hansen TV, Jønson L, Albrechtsen A et al (2009) Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families. Breast Cancer Res Treat 115(2):315–323. doi: 10.1007/s10549-008-0088-0",
      "volume": "115",
      "year": "2009"
    },
    {
      "author": "S Holm",
      "first-page": "65",
      "journal-title": "Scand J Stat",
      "key": "9875_CR25",
      "unstructured": "Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6:65–70",
      "volume": "6",
      "year": "1979"
    },
    {
      "DOI": "10.1038/nrc1431",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "665",
      "journal-title": "Nat Rev Cancer",
      "key": "9875_CR26",
      "unstructured": "Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4:665–676",
      "volume": "4",
      "year": "2004"
    },
    {
      "DOI": "10.1093/jnci/94.18.1358",
      "author": "D Thompson",
      "doi-asserted-by": "crossref",
      "first-page": "1358",
      "journal-title": "J Natl Cancer Inst",
      "key": "9875_CR27",
      "unstructured": "Thompson D, Easton DF, Breast Cancer Linkage Consortium (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358–1365",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s10549-009-0611-y",
      "author": "SM Domchek",
      "doi-asserted-by": "publisher",
      "first-page": "409",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9875_CR28",
      "unstructured": "Domchek SM, Gaudet MM, Stopfer JE et al (2010) Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2. Breast Cancer Res Treat 119:409–414. doi: 10.1007/s10549-009-0611-y",
      "volume": "119",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.cancergencyto.2005.12.016",
      "author": "M Thomassen",
      "doi-asserted-by": "crossref",
      "first-page": "168",
      "journal-title": "Cancer Genet Cytogenet",
      "key": "9875_CR29",
      "unstructured": "Thomassen M, Gerdes A-M, Cruger D et al (2006) Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark. Cancer Genet Cytogenet 168:168–171",
      "volume": "168",
      "year": "2006"
    },
    {
      "DOI": "10.1111/cge.12360",
      "author": "M Szwiec",
      "doi-asserted-by": "publisher",
      "first-page": "288",
      "journal-title": "Clin Genet",
      "key": "9875_CR30",
      "unstructured": "Szwiec M, Jakubowska A, Górski B et al (2015) Recurrent mutations of BRCA1 and BRCA2 in Poland: an update. Clin Genet 87:288–292. doi: 10.1111/cge.12360",
      "volume": "87",
      "year": "2015"
    },
    {
      "author": "JM Satagopan",
      "first-page": "3776",
      "journal-title": "Clin Cancer Res",
      "key": "9875_CR31",
      "unstructured": "Satagopan JM, Boyd J, Kauff ND et al (2002) Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Clin Cancer Res 8:3776–3781",
      "volume": "8",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.ejca.2004.09.008",
      "author": "T Rafnar",
      "doi-asserted-by": "crossref",
      "first-page": "2788",
      "journal-title": "Eur J Cancer",
      "key": "9875_CR32",
      "unstructured": "Rafnar T, Benediktsdottir KR, Eldon BJ et al (2004) BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study. Eur J Cancer 40:2788–2793",
      "volume": "40",
      "year": "2004"
    },
    {
      "DOI": "10.1136/jmedgenet-2014-102336",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "573",
      "journal-title": "J Med Genet",
      "key": "9875_CR33",
      "unstructured": "Evans DG, Harkness E, Lalloo F, Howell A (2014) Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies. J Med Genet 51:573–580. doi: 10.1136/jmedgenet-2014-102336",
      "volume": "51",
      "year": "2014"
    },
    {
      "DOI": "10.1200/JCO.2014.59.0463",
      "author": "JR Vos",
      "doi-asserted-by": "publisher",
      "first-page": "2553",
      "journal-title": "J Clin Oncol",
      "key": "9875_CR34",
      "unstructured": "Vos JR, Hsu L, Brohet RM et al (2015) Bias correction methods explain much of the variation seen in breast cancer risks of BRCA1/2 mutation carriers. J Clin Oncol 33:2553–2562. doi: 10.1200/JCO.2014.59.0463",
      "volume": "33",
      "year": "2015"
    }
  ],
  "reference-count": 34,
  "references-count": 34,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-016-9875-7"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "15"
}